Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Oral Antibiotics Market: By Class: Beta Lactam and Beta Lactamase Inhibitors, Quinolones, Macrolides, Others; By Application; By Drug Origin; By Spectrum of Activity; By Drug Type; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Oral Antibiotics Market Outlook

The global oral antibiotics market attained a value of over USD 18,365.8 million in 2021. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 2.7% to reach more than USD 23,306.1 million by 2027.

 

Extensive Use of Oral Antibiotics to Treat Infectious Diseases Driving the Market Growth

The extensive use of oral antibiotics for the treatment of infectious diseases, such as influenza and tuberculosis, among others, is aiding the market growth. As oral antibiotics are extensively prescribed for mild issues such as cough, their demand is significantly surging. The increasing cost-effectiveness of oral antibiotics in both developed and developing countries is also fuelling the market growth.

 

Global Oral Antibiotics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Furthermore, the increasing approvals of oral antibiotics by government bodies to enhance treatment options for infectious diseases is augmenting the market growth. For instance, in August 2019, the Food and Drug Administration (FDA) of the United States approved Xenleta (lefamulin) for the treatment of community-acquired bacterial pneumonia.

The growing prevalence of urinary tract infections (UTIs), especially in women, is significantly surging the demand for oral antibiotics such as Fosfomycin and ceftriaxone, among others. Oral antibiotics such as analgesic to relieve pain are also prescribed for the treatment of such infections, which is bolstering the market growth. As the accessibility to healthcare in low-income countries is increasing due to various government initiatives, patients are increasingly seeking treatment of urinary tract infections (UTIs), hence driving the market for oral antibiotics. Moreover, the development of multidrug oral antibiotics for the effective treatment of urinary tract infections (UTIs) is anticipated to provide further impetus to the growth of the market in the forecast period.

 

Oral Antibiotics: Market Segmentation

Oral antibiotics refer to medical drugs such as tablets and capsules that are administered orally and are used to treat mild to moderate infections in the body. They eliminate the risk of canula-related infections to enhance the cost-effectiveness while effectively treating infectious diseases. Moreover, oral antibiotics are typically used to kill microbes in the body.

The major classes of oral antibiotics are:

  • Beta Lactam and Beta Lactamase Inhibitors
  • Quinolones
  • Macrolides
  • Others

The beta lactam and beta lactamase inhibitors segment is further divided into penicillin and cephalosporin, among others.

The market can be broadly categorised on the basis of its applications into:

  • Community-Acquired Respiratory Tract Infections (CARTIs)
  • Urinary Tract Infections (UTIs)
  • Dental
  • Others

The community-acquired respiratory tract infections (CARTIs) segment is bifurcated into upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTIs). Meanwhile, the dental segment is classified into combination and monotherapies.

Based on drug origin, the market is divided into:

  • Natural
  • Semisynthetic
  • Synthetic

By spectrum of activity, the market is bifurcated into:

  • Broad-spectrum Antibiotic
  • Mid/Narrow-spectrum Antibiotic

The market, based on drug type, is classified into:

  • Branded
  • Generics

The EMR report looks into the regional markets of oral antibiotics like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Increasing Research Activities to Develop New Oral Antibiotics to Propel the Market Growth

The growing focus on global health threats, in the wake of the COVID-19 pandemic, is increasing the requirement for the development of new oral antibiotics, which is anticipated to drive the industry growth. As the development of new oral antibiotics is extremely complex, various antibacterial research activities are initiated to understand the structure of bacteria, which is estimated to propel the market growth. Leading companies are increasingly partnering with private and public bodies to accelerate research and development (R&D) activities to address barriers in discovering novel oral antibiotics. This, in turn, is estimated to contribute significantly to the market for oral antibiotics in upcoming years.

The increasing investment in the development of innovative oral antibiotics is projected to augment the industry growth. The introduction of various regulatory standards by healthcare bodies to effectively standardise guidelines for clinical trials of oral antibiotics is projected to augment the market growth. With the rising interest in transforming the goals of antibiotics therapy to neutralise the microbes and boost resistance to diseases, the use of oral antibiotics for the treatment of serious infections is anticipated to increase, which is predicted to aid the market growth in the forecast period.

 

Key Industry Players in the Global Oral Antibiotics Market

The report presents a detailed analysis of the following key players in the global oral antibiotics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Glaxosmithkline plc
  • Abbott Laboratories
  • Allergan Plc
  • Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical
and Forecast Market Analysis by Segment- Class, Application, Drug Origin, Spectrum of Activity, Drug Type, Region
Breakup by Class Beta Lactam and Beta Lactamase Inhibitors, Quinolones, Macrolides, Others
Breakup by Application Community-Acquired Respiratory Tract Infections (CARTIs), Urinary Tract Infections (UTIs), Dental, Others
Breakup by Drug Origin Natural, Semisynthetic, Synthetic
Breakup by Spectrum of Activity Broad-spectrum antibiotic, Mid/Narrow-spectrum antibiotic
Breakup by Drug Type Branded, Generics
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Glaxosmithkline plc, Abbott Laboratories, Allergan Plc, Hoffmann-La Roche Ltd., Pfizer Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Oral Antibiotics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Oral Antibiotics Historical Market (2017-2021) 
    8.3    Global Oral Antibiotics Market Forecast (2022-2027)
    8.4    Global Oral Antibiotics Market by Class
        8.4.1    Beta Lactam and Beta Lactamase Inhibitors
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Penicillin
                8.4.1.4.2    Cephalosporin
                8.4.1.4.3    Others
        8.4.2    Quinolones
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Macrolides
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Others
    8.5    Global Oral Antibiotics Market by Application
        8.5.1    Community-Acquired Respiratory Tract Infections (CARTIs)
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
            8.5.1.4    Breakup by Type
                8.5.1.4.1    Upper Respiratory Tract Infections (URTI)
                8.5.1.4.2    Lower Respiratory Tract Infections (LRTIs)
        8.5.2    Urinary Tract Infections (UTIs)
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Dental
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
            8.5.3.4    Breakup by Type
                8.5.3.4.1    Combination
                8.5.3.4.2    Monotherapies
        8.5.4    Others
    8.6    Global Oral Antibiotics Market by Drug Origin
        8.6.1    Natural
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Semisynthetic
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Synthetic
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
    8.7    Global Oral Antibiotics Market by Spectrum of Activity
        8.7.1    Broad-spectrum antibiotic
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Mid/Narrow-spectrum antibiotic
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
    8.8    Global Oral Antibiotics Market by Drug Type
        8.8.1    Branded
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2017-2021)
            8.8.1.3    Forecast Trend (2022-2027)
        8.8.2    Generics
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2017-2021)
            8.8.2.3    Forecast Trend (2022-2027)
    8.9    Global Oral Antibiotics Market by Region
        8.9.1    Market Share
            8.9.1.1    North America
            8.9.1.2    Europe
            8.9.1.3    Asia Pacific
            8.9.1.4    Latin America
            8.9.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Glaxosmithkline plc
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Abbott Laboratories
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Allergan Plc
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Hoffmann-La Roche Ltd.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Pfizer Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Oral Antibiotics Market: Key Industry Highlights, 2017 and 2027
2.    Global Oral Antibiotics Historical Market: Breakup by Class (USD Million), 2017-2021
3.    Global Oral Antibiotics Market Forecast: Breakup by Class (USD Million), 2022-2027
4.    Global Oral Antibiotics Historical Market: Breakup by Application (USD Million), 2017-2021
5.    Global Oral Antibiotics Market Forecast: Breakup by Application (USD Million), 2022-2027
6.    Global Oral Antibiotics Historical Market: Breakup by Drug Origin (USD Million), 2017-2021
7.    Global Oral Antibiotics Market Forecast: Breakup by Drug Origin (USD Million), 2022-2027
8.    Global Oral Antibiotics Historical Market: Breakup by Spectrum of Activity (USD Million), 2017-2021
9.    Global Oral Antibiotics Market Forecast: Breakup by Spectrum of Activity (USD Million), 2022-2027
10.    Global Oral Antibiotics Historical Market: Breakup by Drug Type (USD Million), 2017-2021
11.    Global Oral Antibiotics Market Forecast: Breakup by Drug Type (USD Million), 2022-2027
12.    Global Oral Antibiotics Historical Market: Breakup by Region (USD Million), 2017-2021
13.    Global Oral Antibiotics Market Forecast: Breakup by Region (USD Million), 2022-2027
14.    North America Oral Antibiotics Historical Market: Breakup by Country (USD Million), 2017-2021
15.    North America Oral Antibiotics Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Europe Oral Antibiotics Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Europe Oral Antibiotics Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Asia Pacific Oral Antibiotics Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Asia Pacific Oral Antibiotics Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Latin America Oral Antibiotics Historical Market: Breakup by Country (USD Million), 2017-2021
21.    Latin America Oral Antibiotics Market Forecast: Breakup by Country (USD Million), 2022-2027
22.    Middle East and Africa Oral Antibiotics Historical Market: Breakup by Country (USD Million), 2017-2021
23.    Middle East and Africa Oral Antibiotics Market Forecast: Breakup by Country (USD Million), 2022-2027
24.    Global Oral Antibiotics Market Structure

Key Questions Answered in the Report

In 2021, the global oral antibiotics market attained a value of over USD 18,365.8 million.

The market is projected to grow at a CAGR of 2.7% between 2022 and 2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach more than USD 23,306.1 million by 2027.

The market is being propelled by the extensive use of oral antibiotics for the treatment of infectious diseases, the increasing approvals of oral antibiotics by governments, and the growing prevalence of urinary tract infections (UTIs).

The industry is estimated to be fuelled by the growing focus on global health threats, the rising attempts to develop new antibiotics, and the increasing investment in research and development (R&D) activities of oral antibiotics.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major classes of oral antibiotics in the industry are beta lactam and beta lactamase inhibitors, quinolones, and macrolides, among others.

The significant applications in the market are community-acquired respiratory tract infections (CARTIs), urinary tract infections (UTIs), and dental, among others.

The different drug origins of oral antibiotics are natural, semisynthetic, and synthetic.

The various spectrum of activities of oral antibiotics are broad-spectrum antibiotic and mid/narrow-spectrum antibiotic.

The major drug types of oral antibiotics are branded and generics.

The major players in the industry are Glaxosmithkline plc, Abbott Laboratories, Allergan Plc, Hoffmann-La Roche Ltd., and Pfizer Inc., among others.

Analyst Review

The global oral antibiotics market attained a value of over USD 18,365.8 million in 2021, driven by the extensive use of oral antibiotics for the treatment of infectious diseases. Aided by the growing focus on global health threats, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 2.7%. The market is projected to reach more than USD 23,306.1 million by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its classes, the oral antibiotics industry can be segmented into beta lactam and beta lactamase inhibitors, quinolones, and macrolides, among others. By applications, the market is categorised into community-acquired respiratory tract infections (CARTIs), urinary tract infections (UTIs), and dental, among others. On the basis of drug origins, the industry is divided into natural, semisynthetic, and synthetic. Based on spectrum of activities, the market is classified into broad-spectrum antibiotic and mid/narrow-spectrum antibiotic. By drug types, the market is bifurcated into branded and generics. The major regional markets for oral antibiotics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Glaxosmithkline plc, Abbott Laboratories, Allergan Plc, Hoffmann-La Roche Ltd., and Pfizer Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER